| Model 20066 Left Ventricular (LV) Lead Study (NCT01365234) | Medtronic Cardiac Rhythm and Heart Failure | 2011-07-01 |
| Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate Vaccine (NCT01285141) | St George's, University of London | 2011-07-01 |
| Safety and Tolerability of RNS60 Given by IV to Healthy Subjects (NCT01264783) | Revalesio Corporation | 2011-07-01 |
| Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors (NCT01364844) | Daiichi Sankyo | 2011-07-01 |
| Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition (NCT02297854) | Dr. Reddy's Laboratories Limited | 2011-07-01 |
| Inhaled Nitric Oxide for the Adjunctive Therapy of Severe Malaria: a Randomized Controlled Trial (NCT01255215) | University Health Network, Toronto | 2011-07-01 |
| Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease (NCT01369225) | Pfizer | 2011-07-01 |
| Pharmacodynamics of Nasal and Buccal Midazolam Using EEG (NCT01316445) | Columbia University | 2011-07-01 |
| Study Of Single Doses Of PF-06291826 (Tafamidis) In Japanese And Western Subjects (NCT01369836) | Pfizer | 2011-07-01 |
| Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants (NCT01391663) | Takeda | 2011-07-01 |
| Pharmacokinetics of RLX030 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy Subjects (NCT01433458) | Novartis Pharmaceuticals | 2011-07-01 |
| A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients (NCT01396161) | Pfizer | 2011-07-01 |
| Computerized Attention Training for Individuals With Acquired Brain Injury (NCT01641432) | Posit Science Corporation | 2011-07-01 |
| Stem Cell Educator Therapy in Type 2 Diabetes (NCT01415726) | University of Illinois at Chicago | 2011-07-01 |
| A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet and Conventional Tablet Under With Water Intake (NCT01394653) | Astellas Pharma Inc | 2011-07-01 |
| Comparative Pharmacokinetics of YH14659 (NCT01422109) | Yuhan Corporation | 2011-07-01 |
| A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults (NCT01399788) | Pfizer | 2011-07-01 |
| A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects (NCT01404091) | BlackThorn Therapeutics, Inc. | 2011-07-01 |
| Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis (NCT01174511) | Hadassah Medical Organization | 2011-07-01 |
| A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002) (NCT01390441) | Merck Sharp & Dohme LLC | 2011-07-01 |
| Safety, Tolerability, and Pharmacodynamics of RDX5791 in Healthy Volunteers (NCT02796131) | Ardelyx | 2011-07-01 |
| A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose. (NCT01408355) | Pfizer | 2011-07-01 |
| ENGAGED: E-Networks Guiding Adherence to Goals for Exercise and Diet (NCT01051713) | Northwestern University | 2011-07-01 |
| A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer (NCT01784107) | Gachon University Gil Medical Center | 2011-07-01 |
| Study of the Safety, Tolerability, Pharmacokinetics and Safety of BG00010 (Neublastin) in Subjects With Sciatica. (NCT01405833) | Biogen | 2011-07-01 |
| A Relative Bioavailability and Food Effect Study of New Formulations (NCT01398475) | Eli Lilly and Company | 2011-07-01 |
| Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea (NCT01382095) | U.S. Army Medical Research and Development Command | 2011-07-01 |
| Pharmacokinetics of BF2.649 in Renal Impairment (NCT01619033) | Bioprojet | 2011-07-01 |
| A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers (NCT01340248) | Chong Kun Dang Pharmaceutical | 2011-07-01 |
| Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W) (NCT01376895) | Nova Southeastern University | 2011-07-01 |
| Multiple Ascending Dose Study of GLPG0492 in Healthy Subjects (NCT01397370) | Lakefront Biotherapeutics NV | 2011-07-01 |
| Tolerance of Intranasal Administration of OT in Prader-Willi Newborn Babies (NCT01548521) | University Hospital, Toulouse | 2011-07-01 |
| First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94 (NCT01372137) | TME Pharma AG | 2011-07-01 |
| Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma (NCT01884428) | Armando Santoro, MD | 2011-07-01 |
| PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma (NCT01393912) | St. Jude Children's Research Hospital | 2011-07-01 |
| Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder (NCT01423916) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-07-01 |
| Sober Network IPT for Perinatal Women With Comorbid Substance Use and Depression (NCT01550913) | Women and Infants Hospital of Rhode Island | 2011-07-01 |
| Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer (NCT01317199) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-07-01 |
| Asian Phase I Study Of PF-03446962 (NCT01337050) | Pfizer | 2011-07-01 |
| Psychosocial Benefits of Exercise in Endometrial Cancer Survivors (NCT01401829) | University of Alabama at Birmingham | 2011-07-01 |
| Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP (NCT01531530) | University of Maryland, Baltimore | 2011-07-01 |
| Brain Stimulation-aided Stroke Rehabilitation: Neural Mechanisms of Recovery (NCT01539096) | The Cleveland Clinic | 2011-07-01 |
| Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors (NCT01391533) | Sanofi | 2011-07-01 |
| Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia (NCT01518556) | Konkuk University Medical Center | 2011-07-01 |
| Open-Label Hepatic Impairment Study (NCT01497327) | Gilead Sciences | 2011-07-01 |
| Allogenic Stem Cell Therapy in Patients With Acute Burn (NCT01443689) | Shenzhen Beike Bio-Technology Co., Ltd. | 2011-07-01 |
| Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma (NCT01390571) | Cancer Research UK | 2011-07-01 |
| First-in-Human Study With GNbAC1 in Healthy Volunteers (NCT01699555) | GeNeuro Innovation SAS | 2011-07-01 |
| Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies (NCT01399840) | Pfizer | 2011-06-30 |
| An Open-label, Dose Escalation, Pharmacodynamic, Pharmacokinetic, and Effect of Food Phase 1 Study of E7820 to Determine the Maximum Tolerated Dose Following Twice Daily Oral Administration in Subjects With Unresectable Solid Tumors (NCT01773421) | Eisai Inc. | 2011-06-30 |
| Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. (NCT01471678) | GlaxoSmithKline | 2011-06-30 |
| FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer (NCT02317302) | Washington University School of Medicine | 2011-06-28 |
| Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT01375829) | National Cancer Institute (NCI) | 2011-06-27 |
| Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple Myeloma (NCT01335685) | Millennium Pharmaceuticals, Inc. | 2011-06-27 |
| A Study To Assess Effects Of PF-04958242 On Bold Functional Magnetic Resonance Imaging During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects (NCT01365338) | Biogen | 2011-06-24 |
| A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C (NCT01194037) | HanAll BioPharma Co., Ltd. | 2011-06-23 |
| Imaging of CB1 Receptors Using (11C)SD5024 (NCT01399398) | National Institute of Mental Health (NIMH) | 2011-06-22 |
| Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003) (NCT01353898) | Merck Sharp & Dohme LLC | 2011-06-21 |
| Vaccine Therapy in Treating Patients With Metastatic Solid Tumors (NCT01376505) | Robert Wesolowski | 2011-06-21 |
| A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors (NCT01375842) | Genentech, Inc. | 2011-06-21 |
| A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab (NCT01307267) | Pfizer | 2011-06-21 |
| Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma (NCT01336920) | University of Nebraska | 2011-06-21 |
| Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT01386385) | National Cancer Institute (NCI) | 2011-06-20 |
| Absolute Bioavialability of GSK1120212 (NCT01416337) | GlaxoSmithKline | 2011-06-20 |
| Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors (NCT01379287) | Memorial Sloan Kettering Cancer Center | 2011-06-20 |
| CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies (NCT00968760) | M.D. Anderson Cancer Center | 2011-06-20 |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT01366144) | National Cancer Institute (NCI) | 2011-06-20 |
| Study to Evaluate the Pharmacokinetics of Guaifenesin in Adults and Adolescents (NCT03633448) | Reckitt Benckiser LLC | 2011-06-18 |
| Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML) (NCT01352650) | Weill Medical College of Cornell University | 2011-06-17 |
| Immune Responses to Two Experimental HIV Vaccines in Healthy Adults (NCT01386489) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-06-17 |
| Bioequivalence Minocycline Bioequivalence (NCT01755611) | GlaxoSmithKline | 2011-06-17 |
| A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil (NCT01406145) | Astellas Pharma Inc | 2011-06-16 |
| Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol (NCT07166783) | Otsuka Beijing Research Institute | 2011-06-16 |
| Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy (NCT01345006) | Astellas Institute for Regenerative Medicine | 2011-06-16 |
| A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009) (NCT01370655) | Merck Sharp & Dohme LLC | 2011-06-15 |
| CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors (NCT01386502) | National Cancer Institute (NCI) | 2011-06-15 |
| A Study of IMC-CS4 in Subjects With Advanced Solid Tumors (NCT01346358) | Eli Lilly and Company | 2011-06-15 |
| First Time in Human Study Using GSK2330672 (NCT01416324) | GlaxoSmithKline | 2011-06-15 |
| Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer (NCT01363947) | Genentech, Inc. | 2011-06-14 |
| Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids (NCT01256268) | H. Lee Moffitt Cancer Center and Research Institute | 2011-06-13 |
| Acupuncture to Reduce Signs of Inflammation in Participants With Chronic Low Back Pain (NCT01376375) | National Center for Complementary and Integrative Health (NCCIH) | 2011-06-10 |
| Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (NCT01344993) | Astellas Institute for Regenerative Medicine | 2011-06-09 |
| Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration (NCT01367444) | Sanofi | 2011-06-08 |
| Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy (NCT01369901) | National Institute of Neurological Disorders and Stroke (NINDS) | 2011-06-08 |
| Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid Tumors (NCT01340833) | GlaxoSmithKline | 2011-06-08 |
| Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male (NCT07166887) | Otsuka Beijing Research Institute | 2011-06-07 |
| A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic Diseases (NCT01340911) | Sirtris, a GSK Company | 2011-06-03 |
| A Study To Determine Bioequivalence Between The Commercial Femulen Tablets And A Reformulation Of Femulen Tablets In Healthy Female Subjects (NCT01359163) | Pfizer | 2011-06-01 |
| Pilot Study of Varenicline to Treat Opioid Dependence (NCT01436474) | Mayo Clinic | 2011-06-01 |
| Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer (NCT01387399) | University Hospital, Bonn | 2011-06-01 |
| Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma (NCT01356173) | Genentech, Inc. | 2011-06-01 |
| Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus (NCT01304537) | Kamada, Ltd. | 2011-06-01 |
| A Study on The Effect of Hepatic Impairment on The Pharmacokinetics of RO4917838 (NCT01356550) | Hoffmann-La Roche | 2011-06-01 |
| A Study of LY2216684 in Healthy Females (NCT01373931) | Eli Lilly and Company | 2011-06-01 |
| Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222) (NCT01373450) | Merck Sharp & Dohme LLC | 2011-06-01 |
| A Study to Assess the Effects of Single Ascending Doses of ASP1707 in Healthy Young Japanese Male Subjects (NCT02146742) | Astellas Pharma Europe B.V. | 2011-06-01 |
| Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor (NCT01372618) | NYU Langone Health | 2011-06-01 |
| A Pharmacokinetic and Safety Study of E7080 in Subjects With Mild (10 mg), Moderate (10 mg), and Severe Hepatic Impairment (5 mg) and Normal Hepatic Function (10 mg) (NCT02421042) | Eisai Inc. | 2011-06-01 |
| Pazopanib, Docetaxel, Prednisone Prostate (NCT01385228) | Daniel George, MD | 2011-06-01 |
| Effect of Exercise on Renal Function in Predialysis (NCT02155036) | King's College Hospital NHS Trust | 2011-06-01 |